We further checked the expression level of Mrc2 in the 4 subtypes of BRCA1-deficient mouse mammary tumors, and found Mrc2 was highly expressed in the mesenchymal-like tumors when compared to other 3 subtypes (Figure S10C). This evidence concerns the gene BRCA1 and breast cancer.